Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 1;25(1):343-350.
doi: 10.31557/APJCP.2024.25.1.343.

The Effects of ABT-199 and Dihydroartemisinin Combination on Cell Growth and Apoptosis in Human U937 and KG-1 Cancer Cells

Roya Nazmabadi  1 , Marziyeh Pooladi  1   2 , Jamal Amri  3 , Marayam Darvish  1 , Yusef Abbasi  4 , Hadi Karami  1
Affiliations

The Effects of ABT-199 and Dihydroartemisinin Combination on Cell Growth and Apoptosis in Human U937 and KG-1 Cancer Cells

Roya Nazmabadi et al. Asian Pac J Cancer Prev. .

Abstract

Introduction: Change in the balance of Bcl-2 family proteins is one of the main reasons for resistance of tumor cells to ABT-199. In this study, the effect of dihydroartemisinin on cell growth, apoptosis and sensitivity of the AML cells to ABT-199 was investigated.

Methods: Cell proliferation and survival were assessed by trypan blue staining and MTT assay, respectively. Cell apoptosis was measured by Hoechst 33342 staining and caspase-3 activity assay. The expression levels of Bcl-2, Mcl-1 and Bax mRNA were tested by qRT-PCR.

Results: Our data showed that combination therapy significantly reduced the IC50 value and synergistically decreased the AML cell survival and growth compared with dihydroartemisinin or ABT-199 alone. Treatment with each of ABT-199 or dihydroartemisinin alone clearly enhanced the Bax mRNA expression and inhibited the expression of Mcl-1 and Bcl-2 mRNA. Inhibition of Mcl-1 mRNA by dihydroartemisinin was associated with enhancement of apoptosis induced by ABT-199 in AML cells.

Conclusion: In conclusion, dihydroartemisinin not only triggers the intrinsic pathway of apoptosis, but also can increase the sensitivity of the AML cells to ABT-199 via suppression of Mcl-1 expression.

Keywords: ABT-199; AML; Apoptosis; Bcl-2; dihydroartemisinin.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare

Figures

Figure 1
Figure 1
Effect of Dihydroartemisinin and ABT-199 Combination on Cell Survival. The U937 and KG-1 cells were exposed to dihydroartemisinin (DHA) (A) and ABT-199 (B) at indicated concentrations. After 24 h, the cell survival rate was measured using MTT assay. The cell survival curves were plotted using GraphPad 6.1 software (C, D, F and G). Data are showed as mean±SD of three experiments. The combination index (CI) values were determined using the fractional affected (Fa) values of MTT assay and CalcuSyn software (E and H).
Figure 2
Figure 2
Proliferation Inhibition of AML Cells. The U937 and KG-1 cells were treated with ABT-199 and dihydroartemisinin (DHA) for 1-5 day. Next, the cell viability was determined using trypan blue exclusion assay. The data are showed as mean±SD of three experiments. *p<0.05 versus blank control or solvent control
Figure 3
Figure 3
RT-qPCR Analysis of AML Cells. The U937 and KG-1 cells were treated with dihydroartemisinin (DHA) and ABT-199 (IC50 doses) for 24 h. Next, relative mRNA expression levels of Bcl-2 (A and D), Mcl-1 (B and E) and Bax (C and F) were determined by RT-qPCR using 2-(∆∆Ct) method. Results are presented as mean±SD (n=3). #p< 0.05 relative to single treatment; *p<0.05 relative to blank control
Figure 4
Figure 4
The Effect of Dihydroartemisinin and ABT-199 on Apoptosis of AML Cells. U937 and KG-1 cells were exposed to the IC50 doses of dihydroartemisinin (DHA) and ABT-199 for 24 h. Next, the apoptosis was measured using Hoechst 33342 staining (A and B) and caspase-3 activity assay (C and D). The data are expressed as mean±SD (n=3) of three experiments. *p<0.05 compared with blank control. Arrows show the apoptotic cells
See this image and copyright information in PMC

References

    1. Baradaran B, Nazmabadi R, Ariyan Z, Sakhinia E, Karami H. Dual targeting of anti-apoptotic proteins enhances chemosensitivity of the acute myeloid leukemia cells. Asian Pac J Cancer Prev. 2022;23(7):2523–30. - PMC - PubMed
    1. Maffeo B, Panuzzo C, Moraca A, Cilloni D. A leukemic target with a thousand faces: The mitochondria. Int J Mol Sci. 2023;24:17. - PMC - PubMed
    1. Turkalj S, Radtke FA, Vyas P. An overview of targeted therapies in acute myeloid leukemia. HemaSphere. 2023;7(6):e914. - PMC - PubMed
    1. Lauria F, Raspadori D, Rondelli D, Ventura MA, Fiacchini M, Visani G, et al. High bcl-2 expression in acute myeloid leukemia cells correlates with cd34 positivity and complete remission rate. Leukemia. 1997;11(12):2075–8. - PubMed
    1. Pan R, Hogdal LJ, Benito JM, Bucci D, Han L, Borthakur G, et al. Selective bcl-2 inhibition by abt-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov. 2014;4(3):362–75. - PMC - PubMed

MeSH terms